Evaluation of Galectin-1 and Galectin-3 levels in patients with bipolar disorder: Is Galectin-3 associated with treatment response?
Meryem Yüksel AytekinAybeniz Civan KahveRabia Nazik EkinciArzu Sakallı NuralIşık Batuhan ÇakmakNagihan Ayaz NaycıErol GökaPublished in: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) (2024)
Our study is valuable in that it is the first study to show the change in Gal levels after treatment and to evaluate the role of Gal in BD.Gal-1 may play roles in the pathophysiology of BD.Gal-3 may be a biomarker candidate for the evaluation of the treatment response.